About the Cover
Cover image
Repeated 18F-FDG PET can assess survival early during chemoradiotherapy for non–small cell lung cancer, as demonstrated in this typical patient with a responding tumor. See page 1584.
.
Repeated 18F-FDG PET can assess survival early during chemoradiotherapy for non–small cell lung cancer, as demonstrated in this typical patient with a responding tumor. See page 1584.
.
